CATTANEO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 4.595
AS - Asia 2.823
EU - Europa 2.549
SA - Sud America 558
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 10.591
Nazione #
US - Stati Uniti d'America 4.507
CN - Cina 1.147
SG - Singapore 892
UA - Ucraina 773
DE - Germania 521
BR - Brasile 462
IT - Italia 398
HK - Hong Kong 317
VN - Vietnam 160
FI - Finlandia 159
GB - Regno Unito 155
RU - Federazione Russa 151
FR - Francia 138
TR - Turchia 117
IE - Irlanda 109
IN - India 56
CA - Canada 47
AR - Argentina 39
BD - Bangladesh 35
SE - Svezia 28
ZA - Sudafrica 24
MX - Messico 23
PL - Polonia 23
EC - Ecuador 20
BE - Belgio 17
ES - Italia 16
IQ - Iraq 16
JP - Giappone 15
NL - Olanda 15
ID - Indonesia 11
AT - Austria 10
CO - Colombia 10
EU - Europa 10
LT - Lituania 10
PY - Paraguay 8
UZ - Uzbekistan 8
PK - Pakistan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CL - Cile 5
IL - Israele 5
PA - Panama 5
UY - Uruguay 5
AL - Albania 4
AZ - Azerbaigian 4
DZ - Algeria 4
MA - Marocco 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
EG - Egitto 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
MK - Macedonia 3
MU - Mauritius 3
RS - Serbia 3
TN - Tunisia 3
AM - Armenia 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TO - Tonga 1
Totale 10.591
Città #
Jacksonville 534
Fairfield 447
Woodbridge 422
Singapore 394
Hong Kong 317
Houston 304
Ashburn 279
Beijing 268
Ann Arbor 239
Princeton 212
Cambridge 209
Wilmington 198
Nanjing 197
Seattle 172
Chandler 143
Dublin 109
New York 102
Istanbul 96
Los Angeles 94
The Dalles 87
Nanchang 70
Moscow 59
Ho Chi Minh City 58
Des Moines 57
Hebei 57
Helsinki 52
Milan 52
Buffalo 51
Changsha 45
Shenyang 45
São Paulo 39
Hanoi 38
San Diego 35
Kunming 34
Shanghai 33
Tianjin 32
Jiaxing 31
Lancaster 31
Jinan 28
Munich 28
Dallas 26
San Francisco 26
Redondo Beach 21
Toronto 19
Brooklyn 17
Brussels 17
Chicago 17
Hangzhou 16
Rio de Janeiro 16
Charlotte 15
London 15
Nürnberg 15
Verona 15
Warsaw 15
Zhengzhou 15
Atlanta 14
Johannesburg 14
Santa Clara 14
Brescia 13
Orem 13
Rome 13
Tokyo 13
Haikou 12
Mexico City 12
San Mateo 12
Lanzhou 11
Augusta 10
Belo Horizonte 10
Chennai 10
Dhaka 10
Guayaquil 10
Kocaeli 10
Monmouth Junction 10
Ningbo 10
Curitiba 9
Dearborn 9
Phoenix 9
Taiyuan 9
Trieste 9
Denver 8
Guangzhou 8
Taizhou 8
Turku 8
Vienna 8
Boston 7
Da Nang 7
Fuzhou 7
Haiphong 7
Itajaí 7
Lucera 7
Miami 7
Montreal 7
Salvador 7
Siena 7
Stockholm 7
Tashkent 7
Washington 7
Brasília 6
Changchun 6
Genoa 6
Totale 6.378
Nome #
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 199
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 169
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 155
Desensibilizzazione orale alla rifampicina: descrizione di un nuovo protocollo. 146
CD3-CD4+ cells with a Th2-like pattern of cytokine production in the peripheral blood of a patient with cutaneous T cell lymphoma. 146
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 142
In vitro cell death of activated lymphocytes in Omenn's syndrome 142
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 142
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations 135
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 133
Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection 131
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 129
Circulating immune complexes in human acute leukaemia. 129
Studio con TC ad alta risoluzione (HRCT) dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 128
I polimorfismi della metilentetraidrofolatoreduttasi (MTHFR) nel trattamento con methotrexate di pazienti con artrite reumatoide. Revisione della letteratura ed esperienza personale. 124
Esposizione a latice nelle aziende sanitarie: esperienze pratiche 123
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 123
Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. 120
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 116
Anti beta2-glycoprotein I antibodies: clinical significance. 116
Antiperinuclear factor in psoriatic arthropathy 115
Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis. 115
Nonorgan specific autoantibodies and heart damage. 115
Prevenzione delle reazioni allergiche in pazienti sensibilizzati a latice 114
Oesophageal manometry in early and definite systemic sclerosis. 112
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 111
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 111
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 110
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis 109
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. 108
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicentre prospective study. 108
Antiphospholipid antibodies and malignancies 108
EVALUATION OF NEUROLOGICAL MANIFESTATIONS IN 180 PATIENTS (PTS) WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) 108
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 108
Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell-death 107
Antinuclear antibodies in psoriatic arthritis and its subgroups 105
Role of anti-prothrombin in antiphospholipid syndrome. 105
Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers 105
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 104
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 104
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 104
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 103
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA E LUPUS ERITEMATOSO SISTEMICO: DIFFERENZE E SOMIGLIANZE GENETIHE 103
Vasculite orticarioide: valutazione clinica, laboratoristica e terapeutica di 17 pazienti. 102
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 102
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 102
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA: FOCUS SULLE MANIFESTAZIONI NEUROLOGICHE 102
Anticorpi antinucleo e artrite psoriasica 101
MANIFESTAZIONI NEUROLOGICHE IN 180 PAZIENTI CON SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA. RUOLO DEI FATTORI DI RISCHIO CARDIOVASCOLARI 101
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 100
Pregnancy in systemic sclerosis: a prospective study 100
Systemic lupus erythematosus and pregnancy: a prospective study. 99
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 99
Chilblain Lupus Erythematosus (CL) è associato ad anticorpi anti SSA/Ro 98
The anti-beta-2 glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. 97
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis. 97
NEUROLOGICAL MANIFESTATIONS IN 169 PATIENTS WITH PAPS: WHICH SIGNIFICANCE FOR SMALL HYPERINTENSE WHITE MATTER LESIONS AT MAGNETIC RESONANCE IMAGING? 97
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of Low-dose versus high-dose intravenous cyclophosphamide. 96
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 96
Proliferazioni di cloni di tipo Th2 con fenotipo CD3- CD4+. Studio di 2 casi. 95
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 95
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 94
Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. 93
ANTICORPI ANTIFOSFOLIPIDI E NEOPLASIE (aPL E NEOPLASIE) 91
PREGNANCY OUTCOMES IN WOMEN EXPOSED TO BIOLOGIC TREATMENT AND AFFECTED BY CHRONIC ARTHRITIS 91
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 90
Antinuclear antibodies and psoriatic arthritis 90
IL "PROFILO" DEGLI ANTICORPI ANTIFOSFOLIPIDI NELLA SINDROME PRIMARIA COME FATTORE DI RISCHIO PER EVENTI CLINICI: STUDIO DI 175 PAZIENTI 90
Lymphadenopathic and oropharyngeal Kaposi's sarcoma in a drug addict with acquired immunodeficiency syndrome. Immunological abnormalities in peripheral blood and lymphoid tissue 90
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 89
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 88
Esophageal Dysfunction in Patients with Definite and Early Systemic Sclerosis 88
Anti-TNFalpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies. 86
Chillblain lupus erythematosus is associated with antibodies to SSA/Ro 86
IL METHOTREXATE (MTX) E I GENOTIPI DELLA METILENTETRAIDROFOLATOREDUTTASI (MTHFR) NEL TRATTAMENTO DI PAZIENTI ITALIANI CON MALATTIE REUMATICHE 86
Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. 85
The neonatal lupus erythematosus associated with isolated LA(SSB) antibodies. 85
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 84
Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow-up of 148 patients 84
Antiperinuclear factor (APF) in patients with psoriasic arthtritis 82
L'orticaria. 80
Chilblain Lupus Erythematosus (CL) is associated with antibodies SSA/Ro 79
TERAPIE BIOLOGICHE E GRAVIDANZA: RISULTATI DI UNO STUDIO MULTICENTRICO ITALIANO 79
Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. 79
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD). 79
[A high-resolution computed tomographic study of the pulmonary interstitium in systemic autoimmune diseases] Studio con tomografia computerizzata con alta risoluzione dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 78
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 78
Oesophageal dysfunction in patients with definite and early systemic sclerosis 77
Discordance for Systemic LupusErythematosus and Hyper IgE Syndrome in a pair of monozygous twins 76
Chronic urticaria induced by eradication therapy of Helicobacter pilori: a case report. 76
Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. 76
Pretransplant antitumor conditioning (fTBI dose) correlates with bone marrow histology at day 0 in leukemic patients. 76
Lessons from the "Euro-Lupus Cohort". 76
European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". 74
Esofagopatia sclerodermia in pazienti con sclerosi sistemica (SSC) “precoce” secondo Le Roy-Mesdger: confronto con altri subset di malattia. Studio clinico-manometrico di 181 pazienti 74
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases 72
Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients 72
Lupus neonatale: manifestazioni cliniche e rischio di blocco cardiaco congenito in neonati da madri con anticorpi anti-Ro/SSA. 68
Antiphospholipid antibodies and intestinal pathology 68
European Working Party on Systemic Lupus Erythematosus. Lessons from the "Euro-Lupus Cohort". 66
Totale 10.194
Categoria #
all - tutte 50.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021835 0 0 0 0 0 138 45 153 236 78 166 19
2021/2022763 29 152 14 56 12 27 22 56 39 87 70 199
2022/2023576 113 5 5 20 58 173 3 54 96 3 16 30
2023/2024630 53 19 41 31 13 102 21 23 216 3 1 107
2024/20251.500 2 7 5 177 218 116 99 52 149 127 362 186
2025/20262.018 345 503 245 515 305 105 0 0 0 0 0 0
Totale 10.657